Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in
about
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Improvement of fatigue, physic ...... /small lymphocytic lymphoma in
@en
Improvement of fatigue, physic ...... /small lymphocytic lymphoma in
@nl
type
label
Improvement of fatigue, physic ...... /small lymphocytic lymphoma in
@en
Improvement of fatigue, physic ...... /small lymphocytic lymphoma in
@nl
prefLabel
Improvement of fatigue, physic ...... /small lymphocytic lymphoma in
@en
Improvement of fatigue, physic ...... /small lymphocytic lymphoma in
@nl
P2093
P2860
P1433
P1476
Improvement of fatigue, physic ...... c lymphoma in the HELIOS study
@en
P2093
Angela Howes
Ann Janssens
Asher Chanan-Khan
Eric K H Chan
Graeme Fraser
Javier Loscertales
Joris Diels
Marie-Sarah Dilhuydy
Mariya Salman
P2860
P304
P356
10.1080/10428194.2017.1416364
P577
2018-01-03T00:00:00Z